Cart
sales@molnova.com
HS220
CAS No. 1570374-32-1
HS220( —— )
Catalog No. M28488 CAS No. 1570374-32-1
HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 106 | In Stock |
|
| 10MG | 169 | In Stock |
|
| 25MG | 280 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 498 | In Stock |
|
| 200MG | 684 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHS220
-
NoteResearch use only, not for human use.
-
Brief DescriptionHS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
-
DescriptionHS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1570374-32-1
-
Formula Weight323.35
-
Molecular FormulaC18H17N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (257.71 mM)
-
SMILESO=C(O)C1=CC=CC(=C1)C(=O)NC2=NC=3C=CC=CC3N2CCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Zunsemetinib
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.
-
SR-318
SR-318 potently inhibits the TNF-α release in whole blood (IC50 = 283 nM). SR-318 is a potent and highly selective inhibitor of p38 MAPK. The IC50 values are 5 nM, 32 nM and 6.11 μM for p38α, p38β and p38α/β, respectively.
-
Acumapimod
An orally active, potent p38 MAPK inhibitor that potently inhibits ex vivo LPS‐induced TNFα secretion with an IC50 of 44 ng/mL (115 nM).
